Our Laboratory in Naperville, USA

Step Into Our Naperville Facility!

In 2022, we proudly announced the grand opening of our Naperville, Chicago location!

Our new facility is only 30 minutes from the Chicago O’Hare airport and encompasses over 3,000m2 (29,283 sq ft) of innovative scientific equipment and highly trained staff.

As part of CellCarta’s global CRO infrastructure, this lab strengthens our clinical trial support capabilities across North America.

Join us for a tour and see how CellCarta is dedicated to advancing scientific research.

At Naperville, we offer testing services for all phases of clinical trials. As a CRO with multiomics capabilities, we support:

Genomics

Our Naperville facility is designed to provide comprehensive testing services across various phases of clinical trials. Our advanced genomic capabilities include-

• qPCR

• RT-PCR

• Digital PCR

• Nanostring

• Next-generation sequencing

These techniques are essential for precise genetic analysis and biomarker discovery, aiding in the development of targeted therapies and personalized medicine.

Histopathology

In addition to our robust genomic services, we offer state-of-the-art histopathology services.

• Immunohistochemistry (IHC) assays

• In situ hybridization (ISH) assays

• Software platforms: Indica Labs’ HALO®, Visiopharm®,  Akoya’s inForm®, CyteHub®, SoloWeb, and navify® by Roche.

As a CAP/CLIA certified lab, we support clinical studies for diagnostic and pharmaceutical partners in preparation for FDA, EU and other global submissions.

Our histology CRO services are integrated into our multiomic CRO offerings, enabling scalable analysis pipelines for high-volume biomarker testing across platforms and therapeutic areas.

We support both preclinical and clinical studies across oncology, immunology, and more, with specialized support for ADC development programs.

Commitment to Quality and Compliance

As a CAP/CLIA certified laboratory, we adhere to the highest standards of quality and compliance. Our rigorous quality control measures ensure the reliability and accuracy of our data, supporting clinical studies for regulatory submissions worldwide, including FDA and EU approvals.

Strategic Location and Accessibility

Located just 30 minutes from Chicago O’Hare airport, our Naperville facility is easily accessible for local and international clients. The facility spans over 3,000m² (29,283 sq ft) and is equipped with the latest scientific equipment, operated by a team of highly trained professionals dedicated to advancing scientific research.

The location alsoserves as a hub for North American sample processing and analysis.

Why Choose CellCarta?

CellCarta is committed to delivering high-quality, reliable data through our extensive range of testing services and advanced technologies. Our new Naperville facility exemplifies our dedication to supporting clinical trials and research initiatives with state-of-the-art resources and expert staff.

As a  global CRO, our Naperville site provides key clinical trial services in genomics, histopathology, and biomarker programs.

Backed by our expert scientific teams and cutting-edge platforms, we help biopharma clients accelerate drug development timelines with data they can trust.